By Health Capital Consultants, LLC
***
***
U.S. Supreme Court Rules Against HHS in 340B Case
On June 15, 2022, the U.S. Supreme Court released its decision regarding the cuts made by the Department of Health and Human Services (HHS) to the 340B Drug Pricing Program, finding that HHS acted outside its statutory authority in changing reimbursement rates for one group of hospitals without first surveying them on their costs.
The 340B Drug Pricing Program allows hospitals and clinics that treat low-income, medically underserved patients to purchase certain “specified covered outpatient drugs” at discounted prices. (Read more…)
***
COMMENTS APPRECIATED
Thank You
***
***
***
Filed under: Accounting, Breaking News, Drugs and Pharma, Events-Planner, Health Insurance, Op-Editorials | Tagged: 340-B, Health Capital Consultants LLC, HHS, Rules Against HHS Drug Pricing [340-B] Program, Supreme Court |
Leave a Reply